MBD - Moligand™, 10 mM in DMSO , CAS No.33984-50-8

CAS: 33984-50-8 Cat. No.: M1496911 Fórmula: C14H12N4O4 Peso molecular: 300.27 Beilstein Registry Number: 1151390 Número CE: 251-775-9 PubChem CID: 99555
Disponível para encomenda
GRAU & PUREZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. 10 mM in DMSO
Storage
Protected from light,Store at -80°C
Shipped In
Dry ice packs + Cold packs
★
Tamanho
Alemanha (EU)
USA*
Preço
Qtd
1ml
M1496911-1ml
Sob encomenda · 8–12 semanas
55,45€
Enter a quantity for the sizes you want to add.

Visão geral

MBD (7-(p-Methoxybenzylamino)-4-nitrobenz-2,1,3-oxadiazole), a new fluorescent probe for protein and nucleoprotein conformation, is applied to bacterial ribosomes and to bovine trypsinogen and trypsin. MBD is strongly fluorescent upon binding to a hydrophobic area of a macromolecule .

Especificações

Especificações e pureza
Moligand™, 10 mM in DMSO
Condições de armazenamento de armazenamento
Protected from light,Store at -80°C
Enviado em
Dry ice packs + Cold packs
Este produto requer transporte de cadeia fria. Serviços terrestres e outros serviços econômicos não estão disponíveis.
Grau
Moligand™
Nomes e identificadores
SMILES isoméricas
COC1=CC=C(C=C1)CNC2=CC=C(C3=NON=C23)[N+](=O)[O-]
WGK Alemanha
3
PubChem CID
99555
Peso molecular
300.27
Beilstein
1151390

Dados avançados

Certificados(CoA,COO,BSE/TSE e Mapa de Análise)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Propriedades químicas e físicas
Índice de refraçãon20D1.69 (Predicted)
Ponto de ebulição (°C)500.83° C at 760 mmHg (Predicted)
Ponto de fusão (°C)174-177° C
Segurança e perigos (GHS)
WGK Alemanha
3
Calculadoras de soluções
Revisões

Avaliações dos Clientes

Application Protocols

No validated application protocols are supplied for this item.

  • General setup (for small‑molecule ligands)

    • Reconstitution: Prepare a concentrated DMSO stock under low light; vortex/sonicate to clarity.
    • Working dilutions: Add to buffer or media with thorough mixing; maintain consistent vehicle across controls and treatments.
    • Controls: Include vehicle controls, positive reference compounds (if available), and orthogonal readouts to confirm on‑target effects.
    • Stability: Track time‑in‑solution under assay conditions; keep solutions chilled and protected from light.
  • Documentation

    • Record lot number, stock concentration, solvent, preparation date, and storage conditions. Attach CoA to your ELN entry.
  • Not specified for this item

    • Tested applications, recommended dilutions, or positive controls: Not specified for this item; refer to CoA/Spec Sheet.
Biological Roles
  • Item-specific biological targets or modes of action: Not specified for this item; refer to CoA/Spec Sheet and vendor documentation.

  • General role of small‑molecule ligands in life science research

    • Serve as chemical probes to interrogate protein function, pathways, and phenotype by reversible binding or covalent modification.
    • Enable target validation, mechanism studies, and tool compound benchmarking in biochemistry and cell biology.
    • When tagged or conjugated (not specified here), can support affinity enrichment, imaging, or proximity labeling.
  • Experimental considerations

    • Verify on‑target effects via orthogonal assays (e.g., CETSA/thermal shift, SPR/ITC, enzymology) and counter‑screens to deconvolute off‑target or assay‑interference behavior.
    • Assess compound stability in the chosen biological matrix (media, serum, lysate). Use time‑course LC–MS to quantify parent vs. degradants.
    • Control for vehicle effects (DMSO/Ethanol) by matched solvent controls across all concentrations.
  • Compliance note

    • This product is for research use only. No clinical/diagnostic use is implied or permitted.
Buffer Applications

Because the structure and ionization properties are not specified, detailed buffer recipes cannot be provided for this item.

  • General guidance for preparing working solutions

    • Stock solution: Prepare a concentrated DMSO stock (e.g., 10–50 mM) under subdued light; verify complete dissolution.
    • Dilution: Add stock to the desired buffer (e.g., PBS, HEPES, Tris) while vortexing to the final working concentration, keeping organic cosolvent ≤0.1–1% v/v as assay tolerance allows.
    • pH effects: If the compound is ionizable (unknown here), buffer pH near the ionized state may improve aqueous solubility; verify stability at the chosen pH.
    • Filtration: If particulates remain, 0.22 µm filtration into amber vials can improve clarity; confirm no adsorption losses.
  • Not specified for this item

    • pKa, isoelectric point, buffer compatibility limits, and precise solubility: Not specified for this item; refer to CoA/Spec Sheet.
Green Alternatives
  • Context

    • Specific structural and solvent requirements for MBD are not provided. Therefore, “greener” choices focus on solvent systems and handling practices rather than the molecule itself.
  • Greener solvent considerations (general)

    • Prefer water‑rich systems where feasible; use DMSO/Ethanol as primary cosolvents before DMF/NMP owing to greener profiles.
    • For extractions or workups (if applicable), consider ethyl acetate, 2‑MeTHF, or CPME as greener alternatives to chlorinated solvents, balancing performance against assay compatibility.
  • Practical green tactics

    • Prepare high‑concentration stocks to minimize solvent volumes in assays.
    • Use micro‑scale workflows and low‑bind labware to reduce waste.
    • Store in durable amber vials to extend shelf life and reduce remake cycles.
  • Tradeoffs

    • Switching to greener solvents may change solubility, stability, or target engagement. Always re‑qualify assay performance after any solvent change.
  • Not specified for this item

    • Intrinsic environmental metrics (biodegradability, hazard category, life‑cycle data): Not specified for this item; refer to SDS and product stewardship resources.
Pharmaceutical Uses
  • Regulatory and usage status

    • This product is labeled For research use only. It is not intended for human or veterinary use, clinical diagnostics, or as an active pharmaceutical ingredient (API).
  • Excipient/formulation context

    • No pharmacopeial status, excipient roles, or GMP attributes are provided for this item.
  • Guidance for formulation scientists (general, non‑clinical)

    • If formulating for in vitro studies, define solvent vehicles (e.g., DMSO/EtOH) and evaluate compatibility with your biological system.
    • For in vivo preclinical exploration (if applicable under institutional approvals), establish full toxicology and quality characterization; such data are not supplied here and must be generated independently.
  • Not specified for this item

    • Any compendial monograph alignment (USP/EP/JP), residual solvent class limits, elemental impurities profile, or stability indicating methods: Not specified for this item; refer to CoA/Spec Sheet.
Physical Properties
  • Item-specific facts (from Product Data)

    • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight (exact): Not specified for this item; refer to CoA/Spec Sheet.
  • Physical constants (literature/general guidance)

    • Boiling point, melting point, density, refractive index, pKa, logP, and UV–Vis characteristics: Not specified for this item; refer to CoA/Spec Sheet.
    • For small-molecule ligands similar to MBD, characterization typically includes: DSC or melting range for solids, Karl Fischer moisture, HPLC purity/area %, and UV–Vis profile if the chromophore is present (all values are lot-specific; consult CoA).
  • Solubility considerations (general guidance)

    • Begin with analytical-grade, anhydrous DMSO to form a concentrated stock. Typical screening: 10–50 mM in DMSO, vortex/sonicate, then dilute into assay buffer keeping final DMSO ≤0.1–1% v/v as system permits.
    • If aqueous solubility is desired, evaluate co‑solvent systems (DMSO, DMF, PEG400) or surfactant-assisted vehicles (0.01–0.1% Tween‑20) as compatible with your biology.
    • For ionizable compounds, solubility can often be improved by adjusting pH toward the ionized state; confirm compound pKa first (not provided here).
  • Stability notes (general)

    • Protect from light (as specified). Many light‑sensitive ligands exhibit photobleaching or oxidation; work under low-light and use amber vials.
    • Minimize thermal excursions; store and transport on dry ice as provided.
Quality and Grades
  • Item-specific grade

    • Grade: Moligand™ (from Product Data)
  • What Moligand™ typically implies (general description; verify CoA for this item)

    • Intended for research use as a small‑molecule ligand or probe in life‑science workflows.
    • Emphasis on identity confirmation (e.g., MS) and chemical purity (e.g., HPLC area %). Exact acceptance criteria, stabilizers, counter‑ions, or salt forms are lot‑specific and not provided here.
  • What is NOT specified for this item (consult CoA/Spec Sheet)

    • Absolute purity value, water content, residual solvents, metal assay, stabilizers, salt form/polymorph, and UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.
  • Practical guidance for users

    • Request the latest CoA for your lot to obtain: analytical methods/conditions, acceptance limits, and impurity profile.
    • If low UV background is critical (chromatography/assay readouts), confirm UV–Vis spectrum for the lot.
    • If bioassays are sensitive to excipients, confirm whether any stabilizers or counter‑ions are present.
  • Release documentation

    • For regulated or high‑reproducibility experiments, retain CoA, SDS, and shipment temperature logs as part of your QA/QC records.
Reaction and Applications
  • Manufacturer applications provided: None (no verbatim application text supplied).

  • Research use context (general for Moligand‑type small‑molecule ligands)

    • Typical roles include: target engagement studies, binding assays, pulldown/affinity experiments (if conjugatable), and phenotype modulation in cellular/biochemical systems. Specific target(s) for MBD are not provided.
  • Synthetic chemistry note

    • Without a defined structure, proposing named reactions or derivatizations is not appropriate. If you intend to derivatize or immobilize MBD, request the full structural information and reactive handle availability (e.g., amine, carboxyl, azide, alkyne).
  • Practical guidance

    • Validate solubility window in assay‑compatible media before scaling.
    • Establish a stability‑indicating method (e.g., HPLC/LC–MS) to monitor integrity under light exposure and across intended temperature/time profiles.
    • Confirm non‑specific binding to plastics/proteins by recovery studies; use low‑bind plastics if needed.
  • Not specified for this item

    • Reaction families, catalysts, and transformation scope: Not specified for this item; refer to CoA/Spec Sheet and primary literature once identity is confirmed.
Reaction Conditions

Reaction conditions depend entirely on the compound’s functional groups, which are not provided for this item.

  • General guidance

    • If derivatization or conjugation is planned, first determine the presence of nucleophilic/electrophilic handles (e.g., amines, carboxyls, halides, azides/alkynes) and their stability windows.
    • Screen solvent systems that balance solubility and stability (begin with DMSO/DMF; move to greener options as feasible) and control light exposure.
    • Use small‑scale scouting experiments with analytical follow‑up (LC–MS) to map conversion and identify degradants.
  • Not specified for this item

    • Typical temperatures, catalysts, reaction times, or yields: Not specified for this item; refer to primary literature after identity confirmation.
Safety and Handling
  • Item-specific hazard data

    • Signal Word: Not specified for this item; refer to SDS.
    • H‑Statements: Not specified for this item; refer to SDS.
    • GHS Classification: Not specified for this item; refer to SDS.
    • Pictograms: Not specified for this item; refer to SDS.
  • General laboratory precautions (for small-molecule ligands; consult SDS for authoritative guidance)

    • PPE: Lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Use a certified chemical fume hood for weighing, dissolving, and aliquoting.
    • Avoid inhalation of dust or aerosols; prevent skin/eye contact. Wash thoroughly after handling.
    • Protect from light as specified; use amber glassware/foil wrapping.
    • Thermal sensitivity: Maintain cold chain; avoid repeated freeze–thaw cycles by preparing single‑use aliquots.
  • Incompatibilities and special risks (general)

    • Avoid strong oxidizers/reducers and reactive metals until specific compatibility is known.
    • For potentially moisture‑sensitive materials, handle quickly at room temperature and recap under dry inert gas when feasible.
  • First‑aid overview (general)

    • Skin/eye contact: Rinse with water for ≥15 min; remove contaminated clothing; seek medical attention.
    • Inhalation: Move to fresh air; monitor breathing; seek medical attention.
    • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.

Always defer to the product’s SDS and CoA/Spec Sheet for definitive hazards, spill response, and disposal instructions.

Solvent Selection

Because structural details are not provided, solvent selection must be empirically optimized. The following is general, method‑oriented guidance for small‑molecule ligands.

  • Primary stock solvent

    • Anhydrous DMSO is the default first choice. Prepare a concentrated stock (e.g., 10–50 mM), verify clarity, then perform serial dilutions into assay buffers while keeping final DMSO at system‑tolerated levels (often ≤0.1–1% v/v).
  • Alternatives and cosolvent systems

    • DMF or NMP for challenging hydrophobic compounds; ethanol or isopropanol if biological compatibility requires lower‑toxicity organic content.
    • For aqueous delivery, consider co‑solvent + buffer (e.g., 5–20% DMSO or EtOH in PBS/HEPES) or limited surfactants (e.g., 0.01–0.1% Tween‑20) where compatible with the assay.
  • Polarity and ionization considerations

    • If acidic/basic functional groups are present (unknown here), mild pH adjustment toward the ionized form can improve solubility; confirm compound stability versus pH and light.
  • Practical tips

    • Filter 0.22 µm if particulates persist (verify no adsorption losses).
    • Use amber vials, pre‑chilled pipette tips, and keep solutions on ice during setup to minimize degradation of light/heat‑sensitive analytes.
  • Not specified for this item

    • Dielectric constant, miscibility, and specific solubility values: Not specified for this item; refer to CoA/Spec Sheet.
Storage and Reconstitution
  • Item-specific storage and shipping

    • Storage Conditions: Protected from light; Store at −80°C (from Product Data).
    • Shipped In: Dry ice packs + Cold packs (from Product Data).
  • General reconstitution guidance

    • Allow container to equilibrate briefly at low temperature (e.g., on dry ice to just below 0°C) before opening to minimize moisture ingress.
    • Open under subdued light; use amber vials and foil wrapping during handling.
    • Prepare concentrated stock in anhydrous solvent (commonly DMSO). Verify complete dissolution by visual inspection and, if needed, analytical check (HPLC/LC–MS).
    • Aliquot single‑use portions in low‑bind, amber microvials; purge headspace with inert gas if stability benefits are known or suspected.
  • Working solution stability (general)

    • Keep on ice and protected from light during use; discard if precipitation, discoloration, or significant potency loss is observed.
    • Avoid repeated freeze–thaw; thaw once, use immediately, and refreeze only if stability data support it.
  • Not specified for this item

    • Exact solvent recommendations, maximum stock concentration, solution stability at room temperature or 4°C, and shelf life: Not specified for this item; refer to CoA/Spec Sheet.
Structure and Identity

Brief overview: This listing (MBD, Moligand grade) is positioned as a life-science small‑molecule ligand/research reagent. However, key structural identifiers are not included in the product data provided here.

  • Item-specific facts (from Product Data)

    • SKU: M1496911
    • Product Name: MBD
    • CAS: 33984-50-8
    • PubChem CID: 99555
    • Grade: Moligand™
    • Storage: Protected from light; Store at −80°C
    • Shipped on: Dry ice packs + Cold packs
    • Research use only
    • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
    • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • Structural features

    • Not specified for this item; refer to CoA/Spec Sheet.
  • Practical note

    • If you require structural confirmation (2D/3D depiction, stereochemistry, or functional group mapping), request the CoA/Spec Sheet and spectral package (NMR, MS, HPLC/LC–MS) for this specific lot.
Synthetic Utility

Without structural information, it is not appropriate to claim specific transformations or named‑reaction participation for MBD.

  • General considerations if using as a building block

    • Request full structural details (SMILES/InChI, functional groups, protecting groups, salt form) to assess reactivity, chemoselectivity, and orthogonality.
    • Confirm stability to bases/acids, oxidants/reductants, and common catalysts prior to route design.
    • Establish analytical methods (HPLC/LC–MS, NMR) for in‑process control if MBD is to be used in synthesis.
  • Not specified for this item

    • Functional group content, reactive handles, and typical transformations: Not specified for this item; refer to CoA/Spec Sheet.
Target Specificity
  • Target, pathway, or binding partner(s): Not specified for this item; refer to CoA/Spec Sheet.
  • Species reactivity, clone/isotype (if antibody) or receptor class (if ligand): Not specified for this item; refer to CoA/Spec Sheet.

Given the lack of target annotations, treat MBD as a general small‑molecule reagent until specificity data are obtained from the supplier or generated experimentally (e.g., thermal shift, enzymatic IC50/Ki, affinity methods).

Perguntas frequentes

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at ?80 °C, protected from light. The material is light-sensitive — keep it in its original opaque or amber container.
How is this product shipped?
This product ships frozen with dry ice and cold packs. Unpack on arrival and transfer it to the storage condition stated above; handle dry ice with insulated gloves in a ventilated area.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 33984-50-8, the molecular formula is C14H12N4O4, and the molecular weight is 300.27 g/mol.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Precisa de ajuda para escolher o grau?

O nosso guia de seleção de graus abrange pureza, estado do estabilizador e adequação à aplicação para todas as variantes do nosso catálogo.

Ver o guia de graus Moligand™ →

Deseja que lhe enviemos uma mensagem quando tivermos descontos disponíveis?

Lembrar-me mais tarde

Obrigado! Por favor, verifique a sua caixa de entrada de e-mail para confirmar.

Ops! As notificações estão desativadas.